Key Multiplicity Issues in Clinical Trials I (Introduction)

(33:46)

Key Multiplicity Issues in Clinical Trials I (Module C)

(1:45:24)

Key Multiplicity Issues in Clinical Trials I (Module A)

(19:6)

Key Multiplicity Issues in Clinical Trials I (Module D)

(1:21:1econd)

Key Multiplicity Issues in Clinical Trials I (Module E)

(44:16)

Key Multiplicity Issues in Clinical Trials I (Module F)

(58:)

Key Multiplicity Issues in Clinical Trials (Part I): Introduction

(27:54)

Key Multiplicity Issues in Clinical Trials I (Module B)

(1:10:29)

Key Multiplicity Issues in Clinical Trials I (Module G)

(1:6:34)

Key Multiplicity Issues in Clinical Trials (Part I): Module F

(58:)

Key Multiplicity Issues in Clinical Trials (Part I): Module D

(1:21:1econd)

Key Multiplicity Issues in Clinical Trials (Part I): Module B

(1:10:29)

Online training program (with a Preview of Key Multiplicity Issues in Clinical Trials Part II)

(20:48)

Key Multiplicity Issues in Clinical Trials (Part I): Module A

(19:6)

Key Multiplicity Issues in Clinical Trials (Part I): Module E

(44:16)

Key Multiplicity Issues in Clinical Trials (Part I): Module C

(1:45:24)

Key Multiplicity Issues in Clinical Trials (Part II): Module D

(1:15:24)

Key Multiplicity Issues in Clinical Trials (Part II): Module A

(22:11)